These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37064086)

  • 1. Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma.
    Liu Z; Chen S; Jia W; Qian Y; Yang X; Zhang M; Fang T; Liu H
    Front Oncol; 2023; 13():1113781. PubMed ID: 37064086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
    Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
    Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma.
    Lin YH; Yang YF; Liao JB; Chang TS; Janesha UGS; Shiue YL
    J Cancer; 2023; 14(10):1689-1706. PubMed ID: 37476181
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
    Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
    Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
    Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
    Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
    Liu S; Wang Z
    Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
    Chen Y
    Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
    Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
    Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Chen K; Li L; Mao W; Shen D; Yao N; Zhang L
    Ann Transl Med; 2021 Sep; 9(18):1443. PubMed ID: 34733995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
    Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
    Front Genet; 2023; 14():1041042. PubMed ID: 36936420
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of
    Yao YF; Liu W; Zhou ML; Qiu TL; Wang K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):457-465. PubMed ID: 35642155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exostoisns (EXT1/2) in Head and Neck Cancers: An In Silico Analysis and Clinical Correlates.
    Wang Y; Huang Y; Zhu H; Guo Z; Cheng J; Zhang C; Zhong M
    Int Dent J; 2024 Jun; 74(3):446-453. PubMed ID: 37989698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between the Prognostic Marker LIMA1 in Head and Neck Squamous Cell Carcinoma and Immune Infiltration.
    Huang H; Du Y; Zhao D; Chen K
    J Oncol; 2022; 2022():1040116. PubMed ID: 37181789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermine synthase (
    Pan X; Xue L; Sun Y
    Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
    Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
    Front Immunol; 2022; 13():975847. PubMed ID: 36091055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker Potential of
    Ju Y; Zhu F; Fang B
    Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma.
    Cui K; Yao X; Wei Z; Yang Y; Liu X; Huang Z; Huo H; Tang J; Xie Y
    Front Genet; 2022; 13():917344. PubMed ID: 36186458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.